Marketing-authorisation holder · Poland

Vipharm S.A.

Poland7 medicines1 country

7 medicines in 1 country, as authorisation holder and manufacturer.

Medicines

Every medicine in the registers under its name, current ones first.

7 medicines

Medicine	Substance	Country	Status	Authorised
Abirateron Vipharm 500 mg, filmomhulde tablettenFilmomhulde tablet	Abiraterone	Netherlands	Authorised	2021
Erlotinib Vipharm 100 mg filmomhulde tablettenFilmomhulde tablet	Erlotinib	Netherlands	Authorised	2018
Erlotinib Vipharm 150 mg filmomhulde tablettenFilmomhulde tablet	Erlotinib	Netherlands	Authorised	2018
Erlotinib Vipharm 25 mg filmomhulde tablettenFilmomhulde tablet	Erlotinib	Netherlands	Authorised	2018
Exferana 180 mg, filmomhulde tablettenFilmomhulde tablet	Deferasirox	Netherlands	Authorised	2019
Exferana 360 mg, filmomhulde tablettenFilmomhulde tablet	Deferasirox	Netherlands	Authorised	2019
Fimodigo 0,5 mg, harde capsulesCapsule, hard	Fingolimod	Netherlands	Authorised	2020

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Marketing-authorisation holder · Poland

Vipharm S.A.

Poland7 medicines1 country

7 medicines in 1 country, as authorisation holder and manufacturer.

Its medicines

Medicines

Every medicine in the registers under its name, current ones first.

7 medicines

Medicine	Substance	Country	Status	Authorised
Abirateron Vipharm 500 mg, filmomhulde tablettenFilmomhulde tablet	Abiraterone	Netherlands	Authorised	2021
Erlotinib Vipharm 100 mg filmomhulde tablettenFilmomhulde tablet	Erlotinib	Netherlands	Authorised	2018
Erlotinib Vipharm 150 mg filmomhulde tablettenFilmomhulde tablet	Erlotinib	Netherlands	Authorised	2018
Erlotinib Vipharm 25 mg filmomhulde tablettenFilmomhulde tablet	Erlotinib	Netherlands	Authorised	2018
Exferana 180 mg, filmomhulde tablettenFilmomhulde tablet	Deferasirox	Netherlands	Authorised	2019
Exferana 360 mg, filmomhulde tablettenFilmomhulde tablet	Deferasirox	Netherlands	Authorised	2019
Fimodigo 0,5 mg, harde capsulesCapsule, hard	Fingolimod	Netherlands	Authorised	2020

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Netherlands	7	7	0	Companies All medicines

Also in the registers of Croatia

Therapeutic areas

The ATC groups most of its medicines belong to, largest first.

Antineoplastic agentsAntineoplastic and immunomodulating agents · ATC L01E
All other therapeutic productsVarious · ATC V03A
Endocrine therapyAntineoplastic and immunomodulating agents · ATC L02B
ImmunosuppressantsAntineoplastic and immunomodulating agents · ATC L04A

Top substances

The active substances in most of its medicines.

Names in the registers

How the registers spell it, normalised: legal forms, accents and capitals removed.

vipharm
vipharm s a

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Report an error or request removalCorrections from the company itself are welcome.

At a glance

Type: Marketing-authorisation holder
Headquarters: Poland
Medicines: 7
Countries: 1
Roles: Authorisation holder and manufacturer

Poland: more companies

Ranked by their number of medicines.

Show all